Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesis

Fig. 5

Construction and evaluation of the nomogram for predicting survival in glioma. (A) Nomogram model based on ENU-related risk scores for predicting 1-year, 3-year, and 6-year survival probabilities in glioma patients, where the total points assigned for each risk score sum up to predict the survival probability. (B) Calibration plots show the agreement between nomogram-predicted survival probabilities and observed outcomes for 1-year, 3-year, and 6-year survival, where the x-axis represents the nomogram-predicted probabilities and the y-axis shows the observed fraction survival probabilities. The diagonal line represents perfect prediction, and the points with error bars represent the model performance. DCA assesses the net benefit of the nomogram model at different threshold probabilities for 1-year (C), 3-year (D), and 6-year (E) survival predictions. The x-axes indicate threshold probabilities, and the y-axes show net benefits

Back to article page